Menopause

Menopause
Division of Urogynecology and Reconstructive Pelvic Surgery
Department of OB/GYN

Epidemiology
* Average age is 51.4 years
* 95% confidence interval of Bell Curve gives a range of 45-55 years. Less than 2% occur before age 40.
* Factors associated with early menopause
o Cigarette smoking (1.5 yrs earlier)
o History of short intermenstrual interval
o Family history
o Chemo / Radiation / Genetic factors
* Unrelated to number of prior ovulations, pregnancies, use of OCPs, height, weight, age at menarche, race, class or education

Elderly Population
* In 2000, life expectancy:
o Women 79.7 years
o Men 72.9 years
* Once you reach 65:
o Women expect to live until 84.3 years old
o Men expect to live until 80.5 years old
* Therefore, more than 1/4 of a woman’s life is spent in menopause

Peri-menopause
* Peri-menopause
o Transitional period
+ Hallmark is menstrual irregularities
# Shortened cycle length
# Skipped cycles
# 10% of women will have abrupt cessation of menses
+ Median length of 4-5 years
o Median age of onset is 47.5 years

Physiology
General feature is depletion of follicles with loss of granulosa and thecal cell function
* 6-7 million oocytes at 20 weeks fetal age
* 1 million oocytes at birth drop to 400,000 at puberty
* 300-400 ovulatory events over lifetime
* Accelerated follicular loss 2-8 yrs before menopause

Physiology
* Granulosa cells produce less inhibin, which provides negative feedback for FSH secretion by the pituitary gland.
* Increase in FSH levels
* After menopause, LH levels are also elevated.
* Would you check a FSH or LH level to diagnose menopause?

Symptoms
* Menstrual irregularities is the primary reason women seek medical attention
* Cycles shorten as increased FSH triggers early ovulation
* Skipped cycles due to anovulation
* Long periods of anovulation can lead to excessive estrogen states and irregular, unexpected menses
* Do you think the perimenopausal women can get pregnant?
o YES
o Guinness World Record = 57 yrs & 120 days
o So, remember to recommend contraception. Low does oral contraceptives may be used in women without contraindications (i.e. smoking).
* Hot Flushes
o Subjective feeling of intense heat followed by skin flushing and diaphoresis.
o Sudden dilation of peripheral vasculature secondary to abrupt estrogen withdrawal. Skin temperature increases and core temperature drops.
o Usually, occurs for a few seconds to minutes.
o Duration is about 1-2 years. 25% for > 5 years.
* Genitourinary atrophy
o A variety of symptoms
o Atrophic vaginitis, urethritis, recurrent UTIs, dyspareunia
o Pelvic organ prolapse is NOT caused by estrogen deficiency
* Urinary Incontinence
o Atrophy of estrogen-dependant tissues such as the urethra may contribute to existing causes for urinary incontinence
o Typically addressed with local application of estrogen cream
* Sexual Disturbances
o Decreased interest in sexual activity
+ May be related to decreased testosterone levels
+ May be related to psychosocial stressors
o Anatomic changes secondary to estrogen deficiency
+ Atrophy of vaginal mucosa and lower urethra
+ Thinning of vaginal mucosa with decreased lubrication and elasticity, leading to dyspareunia
* Sleep Disturbances
o Estrogen appears related to producing restful, deep-stage sleep
o Hot flushes more common at night
+ Wakening or disruption of deep-stage sleep
+ Contributes to feeling of overall fatigue
* Mood Swings / Irritability / Depression
o NOT associated with menopausal hormone changes alone
o Stage of life associated with multiple changes (e.g., children leaving home, parents aging, retirement)
o Hot flushes and fatigue can lead to emotional lability
* Cognitive Function
o Some types of memory and brain function may be influenced by estrogen
o Some evidence suggests that Alzheimer’s disease is less frequent in estrogen users and the effect was greater with increasing dose and duration of use.

Adverse Health Effects
* Cardiovascular Disease
o Leading cause of death in US women (f/b malignancies, cerebrovascular disease and MVAs)
o Death rate for CV disease is 3X the rate for breast cancer and lung cancer.
o Changes in lipid profile in menopause
+ Increased LDL
+ Decreased HDL
+ ? Decrease in triglycerides
* Osteoporosis
o Spinal bone density peaks at 20 years, while cortical bone density peaks in late 20s
o Rate of loss of 0.5%/year prior to age 40, then anywhere from 2-9%/year for first 10-15 years after menopause
o Primary loss is trabecular bone, leading to compression fractures, loss of height, kyphosis
o Osteopenia = BMD between -1 and -2.5 SD of a young, white adult woman.
o Osteoporosis = BMD -2.5 or greater SD
o 25-50% of women will have spinal compression fractures by age 70
o 20% of Caucasian women age 80 will have hip fractures, with 15-20% mortality.
o Annual incidence is 1.3% after age 65
o High risk:
+ Caucasian, Asian
+ Thin, inactive, smokers
+ High caffeine/alcohol intake, low dietary calcium, high dietary protein and phosphates
+ H/o oligomenorrhea, excessive exercise, eating disorder
+ Medical conditions – hyperthyroid, cancer, myeloproliferative disorders
o Low Risk:
+ African American
+ Obese, active
o Protection:
+ Ca supplements (1200mg, 1500mg)
+ Weight-bearing exercise
+ HRT: estrogen increases
# Intestinal calcium absorption
# Renal conservation of calcium
# Increases 1,25-dihydroxyvitamin D (active form)
+ Vitamin D (400-800IU)

Hormone Replacement
* Types of hormone replacement
o Estrogen alone (for women without a uterus)
o Estrogen and progesterone
+ Sequential
+ Continuous
o Local estrogen
o SERM’s (Selective Estrogen Receptor Modulators)

HRT - Advantages
1. Relief of vasomotor symptoms
+ HRT is effective in reduces the number of hot flashes
+ 6-8 weeks to see maximal effect
+ Combination HRT (0.625mg estrogen/2.5mg MPA)
+ What about lower doses of HRT?
# For combination HRT, all doses resulted in similar relief of symptoms
# For estrogen alone, most relief with higher doses
2. Vaginal atrophy

# Menopause thins the vaginal epithelium and increases the vaginal pH (> 6.0).
# Estrogen decreases the vaginal pH, thickens the vaginal epithelium and reverses vaginal atrophy.
# Less atrophic changes with higher doses of HRT
3. Bone protection

+ Reduction of bone loss
+ Prevents OP-related hip fractures
+ Protects the spine and the small bones
+ WHI: 5 fewer hip fractures per 10,000 person-yrs
4. Colon cancer

o Some observational studies have suggested a reduced risk.
o WHI: 6 fewer cases / 10,000 person-yrs
1. Endometrial cancer
+ 8-10 fold increased risk with unopposed estrogen.
+ PEPI: unopposed estrogen x 3 yrs = 24% with atypical hyperplasia (vs 1% women on placebo)
+ Risk is increased with:
# Increased duration and dose
# Continuous versus cyclic therapy
# Absence of a progestin
2. Breast cancer

o Meta-analysis of 51 case-controlled & cohort studies showed no increased risk with short-term use.
o After 5 years of use, risk increased by 35%.
o WHI: 8 more invasive cases / 10,000 person-yrs
o Women diagnosed with breast cancer while using HRT have been shown to have better survival

HRT - Disadvantages

3. Thromboembolic disease

o Increases risk for DVT 2 – 3.5 fold
o Strokes: 8 more / 10,000 person-yrs
o PEs: 8 more / 10,000 person-yrs

HRT - Disadvantages

4. Cardiovascular disease:

o Traditionally, HRT was thought to provide protection against coronary heart disease (CHD)
o Observational studies found lower rates of CHD in postmenopausal women on HRT.
o The consensus was that CHD was about 35-50% lower in women using HRT.
o Many studies showed that HRT improved lipid profiles.

HRT - Disadvantages

4. Cardiovascular disease:

o What about secondary prevention? i.e. women who have a h/o coronary heart disease, does HRT help?
o Heart and Estrogen/Progestin Replacement Study (HERS) was a RCT, double-blinded study of 2,763 PM women with intact uteri and a h/o CHD
o 52% higher rate of major coronary events in the 1st year
o Then there was a reduction in the risk with longer use – i.e. 33% lower risk in the 4th and 5th years
o What about primary prevention? i.e. in healthy women, does HRT prevent CHD?
o Women’s Health Initiative (WHI)
o RCT of 16,608 postmenopausal women aged 50-79 years old with an intact uterus
o 40 different US centers
o Combination HRT – 0.625mg CEE and MPA 2.5mg vs placebo

Cardiovascular disease (WHI):
o 7 more CHD events
o 8 more strokes
o 8 more PEs
o 8 more invasive cancers
o Study stopped after 5.2 yrs (planned 8.5yrs) because of cases of breast cancer

SERMs
* Selective estrogen receptor modulators
* Work as agonists and antagonists depending on the tissue
* Raloxifene and tamoxifen

Estrogen Raloxifene Tamoxifen

Prevent OP
Risk Breast
Cancer
Hot Flashes
Endometrial
Cancer
Venous
Thrombosis
SERMs
* Overall, SERMs can help to prevent OP and breast cancer
* However, they aggravate hot flashes, the most common indication for estrogen therapy.
* Also, tamoxifen stimulates the endometrium.

Alternative Medicine
* Limited studies with relatively short duration of therapy and follow-up.
* Soy and isoflavones may be helpful in the short-term (< 2 yrs) for vasomotor sx and may protect against osteoporosis.
* 35-75mg qd isoflavones / day
* Black cohosh may be helpful in the short-term (< 6 mos) for vasomotor symptoms.

Summary
* Health Risks
o Osteoporosis
o Lipid abnormalities
o Cardiovascular disease
o Cancer
* Menopause is the natural course aging of the female reproductive system, driven by loss of oocytes
* Symptoms of menopause include:
o Menstrual irregularities
o Hot flushes
o Sleep disturbances
o Mood changes
o Sexual disturbances
o Urinary incontinence
o Cognitive function
o Hair growth

Hormone Replacement
Benefits
Detriments

* Vasomotor sx
* Vaginal atrophy
* Osteoporosis
* Colon cancer
* Endometrial ca
* Breast ca
* VTE
* CHD

Abnormal Bleeding
* A 44-year old woman presents for evaluation of abnormal menstrual bleeding. Her periods have been regular in the past but for the last 6 months she has had a period every 35-56 days, lasting 7-9 days. The bleeding is heavier than usual and she feels tired all the time. She has gained 15 lbs over the last 2 years, which she believes is due to lack of exercise and increased eating/sleeping. She complains that her skin is dry. Exam is unremarkable. What would your recommend next?
o Check pregnancy test
o Discuss exercise / eating patterns
o Check TSH, PRL
o Consider endometrial biopsy
o Expectant management versus hormonal management

Health Maintenance
* 58 year old postmenopausal woman referred to you by a friend. She has no known medical problems and is on no medications. Her social history is remarkable for an 80-pack/year history of tobacco use. Her physical exam is unremarkable. What are the important health maintenance aspects of the exam to focus on?
o Blood pressure
o Pelvic exam
o Breast exam / mammography
o Fecal occult blood
o Smoking cessation
o Flu shot
o Osteoporosis

Abnormal Bleeding
* A 47 year old woman, G2P2, presents with menstrual cycles varying in length from 20 to 40 days. Until 9 months ago she had regular 28 day cycles. She reports frequent hot flushes. She recently resumed sexual activity and uses no contraception, but she does not desire pregnancy. She does not smoke and has no other medical problems. Her physical exam is unremarkable. What are her options for cycle control?
o Low dose combination oral contraceptive
o Continuous low dose estrogen and progestin menopause regimen
o Cyclic progestin therapy for 12 days a month
o Continuous low dose estrogen (0.625mg conj EE)
o Estradiol vaginal ring

Osteoporosis

* A menopausal patient with osteoporosis has been reading information on the Internet about different treatment modalities for osteoporosis. She wishes to know more about what therapies are actually available and how they work?
o Estrogen: Reduces osteoclast activity
o SERMs: Reduces osteoclast activity
o Bisphosphonates: Reduces osteoclast activity
+ Take on empty stomach, first thing in AM with 8oz water and no food for 30 minutes
+ Take sitting up due to esophagitis risk
+ Calcium supplementation within 4 hours
o Calcium / Vitamin D supplements

Menopause.ppt